GlassScriptPhysician profile
Shani Allred
NPI 1700104445
$1,584.77
in general payments reported to CMS, 2019-2025
20 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $401 · 2023: $283 · 2024: $372 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $314.68 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $166.29 | 2021-2025 | |
| Astellas Pharma US INC | $158.67 | 2024-2025 | Veozah |
| Organon LLC | $149.50 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $139.96 | 2021-2025 | |
| Hologic Sales and Service, LLC | $127.48 | 2022-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Shield Therapeutics INC | $111.82 | 2024-2025 | |
| Exeltis, USA INC. | $94.09 | 2023-2024 | Slynd |
| Abbott Laboratories | $89.43 | 2022 | |
| Baxter Healthcare | $47.37 | 2025 | Perclot |
| Biogen, INC. | $31.03 | 2024 | Zurzuvae |
| Roche Diagnostics Corporation | $20.58 | 2021 | |
| Ethicon US, LLC | $20.02 | 2025 | Stratafix, Vistaseal |
| Novo Nordisk INC | $19.49 | 2024 | |
| Merck Sharp & Dohme LLC | $18.73 | 2023 | Gardasil 9 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.21 | 2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $18.19 | 2022 | |
| Sumitomo Pharma America, INC. | $14.26 | 2025 | Myfembree |
| Avion Pharmaceuticals | $13.18 | 2022 | |
| Agile Therapeutics, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shani Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.